Search for: "Generic Pharmaceutical Services, Inc." Results 881 - 900 of 1,029
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Feb 2022, 5:01 am by Chris Jay Hoofnagle, Simson Garfinkel
Nevertheless, the public can now purchase shares in IonQ Inc., a pure-play quantum computing company that is listed on the New York Stock Exchange through the controversial but increasingly common practice of using a SPAC (special purpose acquisition company). [read post]
13 Apr 2015, 4:22 am by Kevin LaCroix
PwC’s report is generally consistent with the reports previously published by Cornerstone Research and NERA. [read post]
27 Sep 2010, 1:21 pm by Robert Elliott, J.D.
 (workersxzcompxzkit) Vocational Rehabilitation Services California no longer requires vocational rehabilitation services. [read post]
23 Sep 2018, 4:03 pm by Schachtman
Acuity Specialty Products Group, Inc., 639 F.3d 11 (1st Cir. 2011), cert. denied sub nom., U.S. [read post]
5 Jun 2013, 5:29 am by Schachtman
American Medical Systems, Inc., 958 F. [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files opposition: Teva… [read post]
23 Jan 2024, 9:01 pm by renholding
The drug price-fixing conspiracy – which became the focus of investigations by the Department of Justice, 49 state attorney generals, and Congress– has embroiled the generic pharmaceutical industry. [read post]
10 Mar 2008, 1:10 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993); General Electric Co. v. [read post]
21 Dec 2012, 12:27 am by Kevin LaCroix
  Effective policies, training, good tone at the top, and general supervisory authority are just a start. [read post]
27 Oct 2014, 5:27 am
 * Obviousness, common general knowledge and expectations of success: Leo gets a mauling Jeremy hosts this post by Suleman Ali (Holly IP) on Teva UK Limited & Teva Pharmaceuticals Limited v Leo Pharma A/S & Leo Laboratories Limited [2014] EWHC 3096 (Pat), a decision by Mr Justice Birss in the Patents Court, England and Wales which addresses two patent law cornerstones: obviousness and common general knowledge. [read post]
10 May 2011, 10:25 am by Tomassi Law Associates
The case is In re Molecular Insight Pharmaceuticals Inc., 10-23355, U.S. [read post]
17 Sep 2014, 10:30 am by Maureen Johnston
Association of Maryland Pilots 13-1268Issue: Whether, when applying the Chandris, Inc. v. [read post]
22 Jun 2011, 7:57 am by Stephen Albainy-Jenei
  As a result, the Generic Pharmaceutical Association believes Section 12 “could reward patent holders that knowingly falsify information in their original patent application with the USPTO or intentionally omit material information. [read post]
11 Oct 2023, 1:23 am by Roel van Woudenberg
For all designated States except the US, it names Alexion Pharmaceuticals, Inc. and the University of Western Ontario as applicants. [read post]